FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095688730> ?p ?o ?g. }

• W2095688730 endingPage "100" @default.
• W2095688730 startingPage "92" @default.
• W2095688730 abstract "Background: The ALTS (atypical squamous cells of undetermined significance [ASCUS] and low-grade squamous intraepithelial lesion [LSIL] Triage Study) suggests that, for women diagnosed with ASCUS, human papillomavirus (HPV) DNA testing followed by referral to colposcopy of only those women with oncogenic HPV (i.e., HPV DNA testing) is as effective at detecting cervical intraepithelial neoplasia (CIN) 3 or cancer (CIN3+) as referring all women with ASCUS for immediate colposcopy. We conducted a cost-effectiveness analysis of the ALTS trial to determine whether HPV DNA testing is a cost-effective alternative to immediate colposcopy or conservative management with up to three cytology examinations. Methods: Data from the ALTS trial were used in conjunction with medical care costs in a short-term decision model. The model compared the incremental costs per case of CIN3+ detected as measured by the incremental cost-effectiveness ratio (ICER) for the following management strategies for women with ASCUS: immediate colposcopy, HPV DNA testing, and conservative management with up to three cytology examinations. Results: The least costly and least sensitive strategy was conservative management with one repeat cytology examination using a threshold of high-grade squamous intraepithelial lesion (HSIL) for referral to colposcopy. Compared with this strategy, triage to colposcopy based on a positive HPV DNA test result had an ICER of $3517 per case of CIN3+ detected. Immediate colposcopy and conservative management with up to three repeat cytology visits detected fewer cases of CIN3+ and were more costly than HPV DNA testing. Immediate colposcopy became cost-effective at $20 370 compared with HPV DNA testing only if colposcopy and biopsy were assumed to be 100% sensitive. Conclusions: HPV DNA testing is an economically viable strategy for triage of ASCUS cytology. The less than perfect sensitivity of colposcopy and biopsy needs to be accounted for in future clinical guidelines and policy analyses." @default.
• W2095688730 created "2016-06-24" @default.
• W2095688730 creator A5001368845 @default.
• W2095688730 creator A5004454109 @default.
• W2095688730 creator A5008466254 @default.
• W2095688730 creator A5009475462 @default.
• W2095688730 creator A5011063595 @default.
• W2095688730 creator A5012205990 @default.
• W2095688730 creator A5014425846 @default.
• W2095688730 creator A5017159752 @default.
• W2095688730 creator A5020810443 @default.
• W2095688730 creator A5024988697 @default.
• W2095688730 creator A5025709088 @default.
• W2095688730 creator A5027197351 @default.
• W2095688730 creator A5030988530 @default.
• W2095688730 creator A5031542496 @default.
• W2095688730 creator A5033719178 @default.
• W2095688730 creator A5038370602 @default.
• W2095688730 creator A5039777805 @default.
• W2095688730 creator A5040428617 @default.
• W2095688730 creator A5042855794 @default.
• W2095688730 creator A5043264264 @default.
• W2095688730 creator A5050865958 @default.
• W2095688730 creator A5053120905 @default.
• W2095688730 creator A5053516480 @default.
• W2095688730 creator A5053990407 @default.
• W2095688730 creator A5055827569 @default.
• W2095688730 creator A5056799177 @default.
• W2095688730 creator A5058641567 @default.
• W2095688730 creator A5059472615 @default.
• W2095688730 creator A5059951020 @default.
• W2095688730 creator A5068318044 @default.
• W2095688730 creator A5070555068 @default.
• W2095688730 creator A5074359918 @default.
• W2095688730 creator A5076310394 @default.
• W2095688730 creator A5079949843 @default.
• W2095688730 creator A5082251415 @default.
• W2095688730 creator A5086560941 @default.
• W2095688730 creator A5088374519 @default.
• W2095688730 creator A5090964215 @default.
• W2095688730 date "2006-01-18" @default.
• W2095688730 modified "2023-10-18" @default.
• W2095688730 title "Cost-Effectiveness Analysis Based on the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)" @default.
• W2095688730 cites W2004674700 @default.
• W2095688730 cites W2020244769 @default.
• W2095688730 cites W2029317188 @default.
• W2095688730 cites W2051258612 @default.
• W2095688730 cites W2073927517 @default.
• W2095688730 cites W2085497382 @default.
• W2095688730 cites W2121189112 @default.
• W2095688730 cites W2135253681 @default.
• W2095688730 cites W2141196337 @default.
• W2095688730 cites W2147235018 @default.
• W2095688730 cites W333391747 @default.
• W2095688730 cites W4240556999 @default.
• W2095688730 cites W4240777490 @default.
• W2095688730 cites W4245325507 @default.
• W2095688730 cites W4253647827 @default.
• W2095688730 doi "https://doi.org/10.1093/jnci/djj009" @default.
• W2095688730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16418511" @default.
• W2095688730 hasPublicationYear "2006" @default.
• W2095688730 type Work @default.
• W2095688730 sameAs 2095688730 @default.
• W2095688730 citedByCount "93" @default.
• W2095688730 countsByYear W20956887302012 @default.
• W2095688730 countsByYear W20956887302013 @default.
• W2095688730 countsByYear W20956887302014 @default.
• W2095688730 countsByYear W20956887302015 @default.
• W2095688730 countsByYear W20956887302016 @default.
• W2095688730 countsByYear W20956887302017 @default.
• W2095688730 countsByYear W20956887302018 @default.
• W2095688730 countsByYear W20956887302019 @default.
• W2095688730 countsByYear W20956887302020 @default.
• W2095688730 countsByYear W20956887302023 @default.
• W2095688730 crossrefType "journal-article" @default.
• W2095688730 hasAuthorship W2095688730A5001368845 @default.
• W2095688730 hasAuthorship W2095688730A5004454109 @default.
• W2095688730 hasAuthorship W2095688730A5008466254 @default.
• W2095688730 hasAuthorship W2095688730A5009475462 @default.
• W2095688730 hasAuthorship W2095688730A5011063595 @default.
• W2095688730 hasAuthorship W2095688730A5012205990 @default.
• W2095688730 hasAuthorship W2095688730A5014425846 @default.
• W2095688730 hasAuthorship W2095688730A5017159752 @default.
• W2095688730 hasAuthorship W2095688730A5020810443 @default.
• W2095688730 hasAuthorship W2095688730A5024988697 @default.
• W2095688730 hasAuthorship W2095688730A5025709088 @default.
• W2095688730 hasAuthorship W2095688730A5027197351 @default.
• W2095688730 hasAuthorship W2095688730A5030988530 @default.
• W2095688730 hasAuthorship W2095688730A5031542496 @default.
• W2095688730 hasAuthorship W2095688730A5033719178 @default.
• W2095688730 hasAuthorship W2095688730A5038370602 @default.
• W2095688730 hasAuthorship W2095688730A5039777805 @default.
• W2095688730 hasAuthorship W2095688730A5040428617 @default.
• W2095688730 hasAuthorship W2095688730A5042855794 @default.
• W2095688730 hasAuthorship W2095688730A5043264264 @default.
• W2095688730 hasAuthorship W2095688730A5050865958 @default.
• W2095688730 hasAuthorship W2095688730A5053120905 @default.
• W2095688730 hasAuthorship W2095688730A5053516480 @default.

• next